# Exploring Hexarelin's Role in Atherosclerosis and Macrophage Function

Canonical source: https://retacompare.com/research/exploring-hexarelin-s-role-in-atherosclerosis-and-macrophage-function

Growth Hormone Peptides · 2019-11-01


    Hexarelin demonstrates potential in mitigating atherosclerosis by modulating macrophage activity. This synthetic growth hormone secretagogue (GHS) has shown promise in cardiovascular protection, particularly in the context of atherosclerosis (AS). The study under review investigates how hexarelin influences macrophage function and lipid profiles in a mouse model, providing insights that could inform future therapeutic strategies.

 What this study examined

The research focused on the effects of hexarelin on atherosclerosis progression in ApoE(-/-) mice, which are genetically predisposed to develop AS. Over a period of three months, these mice were fed a high lipid diet to induce AS, while receiving either hexarelin (100 µg/kg subcutaneously daily) or saline as a control. Age-matched C57BL/6J mice served as normal controls. Various methods, including histological staining, ELISA, western blotting, confocal microscopy, and flow cytometry, were employed to assess AS development and related signaling pathways.

 Why it matters for Hexarelin research

This study is significant as it expands the understanding of hexarelin's cardiovascular benefits, particularly its effects on macrophages, which play a crucial role in atherosclerosis. By demonstrating that hexarelin can inhibit the uptake of oxidized low-density lipoprotein (ox-LDL) in macrophages, the research highlights a potential mechanism through which hexarelin may exert its protective effects against AS. This could pave the way for further investigations into hexarelin as a therapeutic option for cardiovascular diseases.

 Key findings

Hexarelin treatment resulted in decreased serum total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-c).

There was an increase in serum high-density lipoprotein cholesterol (HDL-c) levels in hexarelin-treated mice.

The formation of atherosclerotic plaques and neointima was significantly attenuated in the hexarelin group compared to the control group.

Hexarelin reduced the expression of CD68 and LOX-1 in aortic tissues, which were elevated in the AS group.

Hexarelin increased growth hormone secretagogue receptor (GHSR) expression in aortic tissues.

The peptide inhibited NF-κB activation and ox-LDL uptake in both the aorta and RAW264.7 macrophages.

 How Hexarelin works (background)

Hexarelin is a synthetic peptide that acts as a growth hormone secretagogue, stimulating the release of growth hormone from the pituitary gland. It has been shown to have cardioprotective effects, potentially through its action on various signaling pathways involved in inflammation and lipid metabolism. The LOX-1-NF-κB signaling pathway, in particular, is crucial in regulating macrophage function and the inflammatory response associated with atherosclerosis. By inhibiting this pathway, hexarelin may reduce macrophage uptake of ox-LDL, thereby mitigating the progression of atherosclerosis.

 Practical takeaways for researchers

Researchers investigating the role of peptides in cardiovascular health may find hexarelin a valuable candidate for further studies. Its ability to modulate lipid profiles and macrophage activity suggests potential applications in treating atherosclerosis and related conditions. Future research could focus on the long-term effects of hexarelin treatment, optimal dosing strategies, and its mechanisms of action in different models of cardiovascular disease. Additionally, exploring the peptide's interactions with other therapeutic agents could enhance understanding of its potential in combination therapies.

 FAQ

 What is hexarelin?

Hexarelin is a synthetic peptide that acts as a growth hormone secretagogue, stimulating the release of growth hormone and potentially offering cardiovascular protective effects.

 How does hexarelin affect atherosclerosis?

Hexarelin has been shown to attenuate atherosclerosis progression by modulating lipid profiles and inhibiting macrophage uptake of oxidized low-density lipoprotein through the LOX-1-NF-κB signaling pathway.

 What are the implications of this research?

The findings suggest that hexarelin may serve as a therapeutic option for atherosclerosis, warranting further investigation into its mechanisms and long-term effects on cardiovascular health.

 Source: PubMed · Peptides · published 2019-11-01.

## Sources

- PubMed · Peptides: https://pubmed.ncbi.nlm.nih.gov/31386895/